Policy, research + analysis

WHAT WE DO

We have extensive experience in both primary and secondary research methods, using a wide range of quantitative and qualitative methodologies. Our approach is always tailored to your project needs — selecting the most appropriate mix of methods to answer the research question with rigour and relevance. Our team regularly conducts:

  • Systematic literature reviews to comprehensively map and appraise peer-reviewed evidence.
  • Scoping and rapid literature reviews to explore the breadth of evidence and identify gaps in emerging or complex fields.
  • Grey literature reviews to incorporate real-world insights from government reports, policy papers, industry sources and conference proceedings.
  • Survey design and analysis, including for healthcare professionals, consumers, and other stakeholders — from instrument development to data analysis.
  • Qualitative interviews, focus groups and roundtables with clinicians, patients, policy experts and industry stakeholders, using structured or semi-structured formats to gather rich insights.
  • Environmental scans and policy mapping to provide a comprehensive understanding of the external landscape affecting a given disease area, therapeutic intervention, or health system challenge.
  • Co-design workshops to engage stakeholders to collaboratively develop interventions that are practical, person-centred, and contextually relevant.
  • Delphi panels to build expert consensus on complex or uncertain issues through structured, multi-round surveys.
  • Observational research to capture real-world behaviours and system interactions to reveal barriers and opportunities not evident through self-report.
  • Journey mapping to visualise the lived experience of patients or carers to identify gaps, pain points, and opportunities across the care pathway.
TAILORED SOLUTIONS
  • White papers – Provides original perspectives or strategic insights to influence debate and shape future policy or practice.
  • Reports – In-depth, evidence-based reports that examine an issue and present clear recommendations for policy, investment, or system change.
  • Budget submissions – Targeted policy proposals aligned with government budget cycles to advocate for funding, reform, or program support.
  • Policy briefs – Concise, accessible summaries of key issues, evidence, and policy recommendations tailored for decision-makers.
  • Horizon scans – Identifies and interprets emerging trends, innovations, or risks that may impact policy, service delivery, or market dynamics.
  • Landscape assessments – Comprehensive overviews of the current state of play in a policy, service, or market environment, highlighting gaps, opportunities, and key stakeholders.
Reports:
Policy research and analysis, Public Health

Fighting Superbugs: Ensuring Australia is ready to combat the rise of drug resistant infections

Evohealth Report Fighting Superbugs: Ensuring Australia is ready to…

Read More

Life Sciences, Policy research and analysis

Cell and gene therapies: Rising to the challenge Scorecard 2023

Scorecard 2023 Measuring Australia’s progress towards timely and…

Read More

Evaluation and economics, Policy research and analysis, Public Health

Time to Act: protecting our children from RSV

Evohealth Report Time to Act: protecting our children from RSVRespiratory..

Read More

Policy research and analysis, Public Health

Preparing Australia: Designing an Australian Centre for Disease Control (CDC)

For many Australians, the COVID-19 pandemic has been their defining…

Read More

Evaluation and economics, Policy research and analysis, Primary Care, Public Health

Cell and gene therapies: Rising to the challenge Scorecard 2023

Evohealth White Paper The burden of cancer in AustraliaIn Australia,…

Read More

Evaluation and economics, Policy research and analysis, Public Health

ASCVD in Taiwan: A public health priority

Evohealth White Paper ASCVD in Taiwan: A public health…

Read More

Life Sciences, Policy research and analysis

Cell and gene therapies: Rising to the challenge

Evohealth White Paper Cell and gene therapies: Rising to the…

Read More

Evaluation and economics, Policy research and analysis, Primary Care

Australia’s Cholesterol Heartache

A simple roadmap for urgent action on cholesterol managementAustralia has…

Read More

WHEN NATIONS COMPETE

Why ‘most favoured nation’ matters for medicine access in Australia

While governments worldwide are debating the impact of MFN on medicine access, we have analysed what it means for Australia.

This is the hottest policy topic in life sciences right now — and we’re the first to put it on the agenda in Australia.

Download the MFN report and discover other key insights from Evohealth.

Check your inbox to download report.